Drug Recalls Center

895 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.

895
Total Drug Recalls
24
High Risk Medications
FDA
Official Source

Important Medication Safety Information

  • Do not stop taking prescribed medications without consulting your healthcare provider
  • Contact your pharmacist or doctor if you have a recalled medication
  • Check lot numbers carefully - not all batches may be affected
  • Return recalled medications to your pharmacy for proper disposal

Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.

HIGHFDA DEVICE

Medtronic MiniMed Recalls Glucose Monitor Due to Software Error

Medtronic MiniMed recalled 12,126 glucose monitoring devices on October 21, 2025. A software error can lead to incorrect glucose readings, risking hypoglycemia or hyperglycemia. Affected consumers should stop using the device immediately and contact their healthcare provider.

Medtronic MiniMed
Software error
Read more
HIGHFDA DEVICE

Mindray Recalls Anesthesia System Over Leakage Risk

Mindray DS USA, Inc. recalled 148 units of the V90 Electronic Vaporizer on October 20, 2025. The recall follows reports of potential anesthesia leakage that could impact patient safety. Healthcare providers and patients must stop using the device immediately.

Mindray DS USA, Inc. dba Mindray North America
Potential for
Read more
HIGHFDA DEVICE

Mindray Vaporizer Recalled Due to Anesthesia Leakage Risk

Mindray DS USA, Inc. recalled 54 units of the Isoflurane V90 Electronic Vaporizer on October 20, 2025. The recall stems from a potential anesthesia leakage issue that poses serious health risks. Affected devices were distributed in the U.S. and Canada.

Mindray DS USA, Inc. dba Mindray North America
Potential for
Read more
HIGHFDA DEVICE

Straumann USA Recalls Emdogain Due to Misuse Risk

Straumann USA recalled 61 units of Emdogain on October 17, 2025. The product, intended for demonstration only, poses a risk if used on patients. Consumers must stop using the affected products immediately.

Straumann USA
The possibility
Read more
HIGHFDA DEVICE

Beckman Coulter Recalls Bicarbonate Reagent Over High Result Risk

Beckman Coulter recalled 36,981 bicarbonate reagents on October 14, 2025. The reagent may produce falsely high bicarbonate results due to interference from Lactate Dehydrogenase. Healthcare providers and patients must stop using it immediately.

Beckman Coulter Ireland
Bicarbonate reagent
Read more
HIGHFDA DEVICE

DermaSensor Recall Due to Risk of Incorrect Skin Cancer Results

DermaSensor recalled 343 diagnostic devices on October 13, 2025, due to a risk of incorrect results. The recall affects nine units specifically identified for failing to meet specifications. This issue could delay patient referrals for necessary treatment.

DERMASENSOR
Potential for
Read more
HIGHFDA DEVICE

Paragon 28 Recalls Fibula Nails Over Surgical Risks

Paragon 28 recalled 20 units of its fibula nail system on October 13, 2025. The recall affects devices with out-of-specification thread depths, risking surgical complications. Patients and healthcare providers must stop using the affected devices immediately.

Paragon 28
Fibula nail
Read more
HIGHFDA DRUG

Karina Daily Moisturizer Recalled Over CGMP Deviations

Beauty4Pros LLC recalled 1,492 tubes of Karina Daily Moisturizer SPF 25 on October 10, 2025. The recall follows concerns regarding current good manufacturing practice (CGMP) deviations. Affected products were distributed in California, Colorado, Florida, Puerto Rico, and Washington.

SUNSCREEN KARINA SKIN CARE MOIST
CGMP Deviations
Read more
HIGHFDA DRUG

Elixir by Coco March Sunscreen Recalled Over CGMP Violations

Elixir by Coco March recalled tinted mineral sunscreen due to CGMP deviations. The recall affects products distributed in California, Colorado, Florida, Puerto Rico, and Washington. Consumers should stop using the product immediately and seek guidance from healthcare providers.

SUNSCREEN
CGMP Deviations
Read more
HIGHFDA DRUG

Sugared+Bronzed Sunscreen Recalled Due to CGMP Deviations

Sugared+Bronzed recalled 2,090 tubes of Tinted Mineral Sunscreen SPF 50 on October 10, 2025. The recall stems from current Good Manufacturing Practice deviations. Consumers should stop using the product immediately and seek guidance.

SUNSCREEN
CGMP Deviations
Read more
HIGHFDA DRUG

CA Botana Recalls Doctor D. Schwab Cream Over Quality Issues

CA Botana International recalled 470 tubes of Doctor D. Schwab Controlling Cream on October 10, 2025. The recall stems from CGMP deviations that pose a high hazard risk. Consumers should stop using the product and seek guidance from healthcare providers.

CONTROLLING CREAM
CGMP Deviations
Read more
HIGHFDA DRUG

Doctor D. Schwab Controlling Balm Recalled for CGMP Deviations

CA BOTANA recalled 555 tubes of Doctor D. Schwab Controlling Balm on October 10, 2025, due to CGMP deviations. The affected product contains salicylic acid and tea tree oil. Consumers should stop using the balm immediately and contact CA BOTANA International for guidance.

CONTROLLING BALM WITH TEA TREE OIL
CGMP Deviations
Read more
HIGHFDA DRUG

Doctor D. Schwab Sunscreen Recalled Due to CGMP Deviations

Doctor D. Schwab recalled 805 tubes of Shimmery Sun Lotion Sunscreen SPF 30 on October 10, 2025. The recall follows significant deviations from current good manufacturing practices (CGMP). Consumers should stop using the product immediately and contact CA BOTANA for guidance.

SHIMMERY SUN
CGMP Deviations
Read more
HIGHFDA DRUG

CA Botana Recalls Doctor. D. Schwab Mineral Sunscreen Over CGMP Violations

CA Botana International recalled 1,167 tubes of Doctor. D. Schwab Mineral Sunscreen SPF 50 on October 10, 2025. The recall stems from current good manufacturing practices (CGMP) deviations. Affected products include Lot Code D54596 with an expiration date of January 31, 2028.

MINERAL SUNSCREEN
CGMP Deviations
Read more
HIGHFDA DRUG

CLEARSTEM Sunscreen Recalled Due to CGMP Deviations

CLEARSTEM recalled 4,890 bottles of YOU ARE SUNSHINE SPF 50 sunscreen on October 10, 2025. The recall follows concerns over CGMP deviations. Consumers should stop using the product immediately and contact their healthcare provider for guidance.

VISAGE
CGMP Deviations
Read more
HIGHFDA DRUG

Doctor D. Schwab Pain Relief Gel Recalled Due to CGMP Violations

Doctor D. Schwab recalled 810 tubes of Clinical Weh Weh Natural Pain Relief Gel on October 10, 2025. The recall stems from CGMP deviations that could compromise product safety. The affected product was distributed in California, Colorado, Florida, Puerto Rico, and Washington.

WEH-WEH PAIN RELIEVER GEL
CGMP Deviations
Read more
HIGHFDA DRUG

CA Botana Recalls Ultra Umbrella Sunscreen Due to CGMP Violations

CA Botana International, Inc. recalled 874 tubes of Ultra Umbrella Sunscreen SPF 30 on October 10, 2025. The recall stems from CGMP deviations that may affect product safety. Consumers in CA, CO, FL, PR, and WA should stop using the product immediately.

ULTRA UMBRELLA
CGMP Deviations
Read more
HIGHFDA DRUG

Elixir by Coco March Sunscreen Recalled Over CGMP Violations

VitaTienda Co U.S.A. recalled 3,295 bottles of Elixir by Coco March Mineral Sunscreen SPF 50 on October 10, 2025. The recall stems from CGMP deviations that could affect product safety. Consumers should stop using the sunscreen immediately and contact their healthcare provider for guidance.

SUNSCREEN
CGMP Deviations
Read more
HIGHFDA DRUG

Gabriel Mineral Sunscreen Recalled Due to CGMP Deviations

Gabriel Cosmetics, Inc. recalled 1,617 tubes of Mineral Sunscreen SPF 50 on October 10, 2025, due to CGMP deviations. The affected product contains 21% zinc oxide and is distributed in California, Colorado, Florida, Puerto Rico, and Washington.

MINERAL SUNSCREEN
CGMP Deviations
Read more
HIGHFDA DRUG

Lannett Company Recalls Niacin Tablets for Failed Dissolution

Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.

NIACIN
Failed Dissolution
Read more
HIGHFDA DRUG

Major Pharmaceuticals Recalls Gabapentin Capsules Over Impurity Risk

Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg on October 10, 2025, due to failed stability testing. The recall affects capsules packaged in blister packs and sold nationwide. Consumers must stop using the product immediately and seek guidance from healthcare providers.

GABAPENTIN
Failed Impurities/Degradation
Read more
HIGHFDA DRUG

CA Botana Recalls Tinted Moisturizer Over CGMP Deviations

CA Botana International recalled 1,401 tubes of Doctor D. Schwab Flawless Skin Fluid Tinted Moisturizer on October 10, 2025. The product may not meet current Good Manufacturing Practices (CGMP). Consumers should stop using it immediately and contact the company for guidance.

SUNSCREEN FLAWLESS SKIN FLUID TINTED
CGMP Deviations
Read more
HIGHFDA DRUG

Dr. Bump Pain Relief Gel Recalled Due to Manufacturing Issues

Dr. Bump Natural Pain Relief Gel has been recalled due to CGMP deviations. 4,890 bottles are affected, distributed in California, Colorado, Florida, Puerto Rico, and Washington. Consumers should stop using the product immediately and contact their healthcare provider for guidance.

DR BUMP GEL 4
CGMP Deviations
Read more

Get Drug Recall Alerts

Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.